P. Rojas

Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab.

P. Tornero, A. Prieto‐García, A. Rodríguez-Fernández, 2019, Journal of investigational allergology & clinical immunology.

Clinical Practice Guidelines for Diagnosis and Management of Hypersensitivity Reactions to Quinolones.

E. Moreno, T. Lobera, N. Blanca-López, 2021, Journal of investigational allergology & clinical immunology.

Toxic epidermal necrolysis induced by levofloxacin.

J. Zubeldia, J. Ruiz-Hornillos, P. Rojas, 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Erythrodysestesia-like skin eruption due to docetaxel with a nonimmediate positive intradermal skin test result.

M. de Barrio, R. Pineda, P. Rojas, 2016, The journal of allergy and clinical immunology. In practice.

Hypersensitivity to repaglinide.

J. Laguna, A. Santos, P. Rojas, 2011, Journal of investigational allergology & clinical immunology.

Adyuvant use of omalizumab in desensitization to chemotherapeutics: beyond ige-mediated reactions.

P. Tornero, A. Prieto‐García, A. Juárez, 2023, Journal of investigational allergology & clinical immunology.